Diagnosis of a rare fetal haemoglobinopathy in the age of next-generation sequencing

BMJ Case Rep. 2016 Apr 19:2016:10.1136/bcr-2016-215193. doi: 10.1136/bcr-2016-215193.

Abstract

Neonatal cyanosis resulting from a fetal methaemoglobin variant is rare. Most such variants are only described in a few published case reports. We present the case of a newborn with unexplained persistent cyanosis, ultimately determined to have a γ-chain mutation causing Hb FM-Fort Ripley. This neonatal haemoglobinopathy can be challenging to diagnose, as significant oxygen desaturation may result from barely detectable levels of the mutant haemoglobin and co-oximetry studies may show a falsely normal methaemoglobin level. Our analysis of the infant's haemoglobin included high-performance liquid chromatography, cellulose acetate electrophoresis and citrate agar electrophoresis, which showed trace amounts of a suspected variant. Ultimately, the diagnosis was made through a novel application of next-generation sequencing (NGS). NGS-based diagnostic approaches are becoming increasingly available to clinicians, and our case provides a framework and evidence for the utilisation of such testing paradigms in the diagnosis of a rare cause of neonatal cyanosis.

Publication types

  • Case Reports

MeSH terms

  • Cyanosis / genetics
  • Female
  • Fetal Diseases / genetics*
  • Fetal Hemoglobin / genetics
  • Hemoglobin M / genetics
  • Hemoglobinopathies / genetics*
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / genetics*
  • Methemoglobin / genetics
  • Mutation
  • Sequence Analysis, DNA / methods*

Substances

  • Methemoglobin
  • Fetal Hemoglobin
  • Hemoglobin M
  • hemoglobin FM Fort Ripley